Tectonic Therapeutic, Inc. TECX
21.56 USD -0.34 (-1.53%)
Nov 10, 2026, 1:40 PM EST
21.16 Day range 22.80
16.77 52-week range 39.53
- YTD
- +3.33%
- 1 year
- +14.17%
News
benzinga.com Tectonic Therapeutic Q3 EPS $(1.08) Beats $(1.33) Estimate Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.08) per share which beat the analyst consensus estimate of $(1.33) by 18.8 percent. This is a 5.88 percent decrease over losses of…
benzinga.com UBS Initiates Coverage On Tectonic Therapeutic with Neutral Rating, Announces Price Target of $26 UBS analyst Alice Nettleton initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Neutral rating and announces Price Target of $26.
benzinga.com Wells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $93 Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:TECX) with a Overweight and lowers the price target from $101 to $93.
benzinga.com Tectonic Therapeutic Q2 EPS $(1.18) Beats $(1.37) Estimate Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.18) per share which beat the analyst consensus estimate of $(1.37) by 13.87 percent. This is a 10.28 percent decrease over losses…
benzinga.com Raymond James Upgrades Tectonic Therapeutic to Strong Buy, Raises Price Target to $81 Raymond James analyst Michael Freeman upgrades Tectonic Therapeutic (NASDAQ:TECX) from Outperform to Strong Buy and raises the price target from $76 to $81.- benzinga.com Tectonic Therapeutic Q1 EPS $(1.34) Misses $(1.18) Estimate Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.34) per share which missed the analyst consensus estimate of $(1.18) by 13.56 percent. This is a 44.09 percent decrease over losses…
benzinga.com Stifel Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $75 Stifel analyst James Condulis initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Buy rating and announces Price Target of $75.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
benzinga.com Tectonic Therapeutic Q4 EPS $(1.03) Beats $(1.10) Estimate Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.03) per share which beat the analyst consensus estimate of $(1.10) by 6.53 percent. This is a 22.62 percent decrease over losses of…- benzinga.com Here's How Much You Would Have Made Owning Tectonic Therapeutic Stock In The Last 5 Years
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
benzinga.com Goodyear Tire Posts Downbeat Earnings, Joins BP, ON Semiconductor And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
benzinga.com Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session - benzinga.com Truist Securities Maintains Buy on Tectonic Therapeutic, Lowers Price Target to $60 Truist Securities analyst Danielle Brill maintains Tectonic Therapeutic (NASDAQ:TECX) with a Buy and lowers the price target from $64 to $60.
- benzinga.com Tectonic Therapeutic Q3 EPS $(1.02) Beats $(1.05) Estimate Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.02) per share which beat the analyst consensus estimate of $(1.05) by 2.86 percent. This is a 15 percent increase over losses of…
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com Oppenheimer Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Target of $80 Oppenheimer analyst Leland Gershell initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Outperform rating and announces Price Target of $80.- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com Canopy Growth, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com Truist Securities Initiates Coverage On Tectonic Therapeutic with Buy Rating, Announces Price Target of $64 Truist Securities analyst Danielle Brill initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Buy rating and announces Price Target of $64.
- benzinga.com Raymond James Reinstates Outperform on Tectonic Therapeutic, Announces $76 Price Target Raymond James analyst Michael Freeman reinstates Tectonic Therapeutic (NASDAQ:TECX) with a Outperform and announces $76 price target.
- benzinga.com Reported Saturday, Tectonic Therapeutic Presents Full Phase 1b Results For TX45 in PH-HFpEF Showing Sustained Hemodynamic Improvements And Strong Safety Profile Data confirmed TX45's tolerability profile and improvements in left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with preserved…
benzinga.com Mizuho Maintains Outperform on Tectonic Therapeutic, Raises Price Target to $85 Mizuho analyst Uy Ear maintains Tectonic Therapeutic (NASDAQ:TECX) with a Outperform and raises the price target from $51 to $85.- benzinga.com Tectonic Therapeutic Q1 EPS $(0.93) Beats $(1.22) Estimate Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(0.93) per share which beat the analyst consensus estimate of $(1.22) by 23.77 percent. This is a 91.52 percent increase over losses…
benzinga.com This Dycom Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - benzinga.com Mizuho Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Target of $51 Mizuho analyst Uy Ear initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Outperform rating and announces Price Target of $51.
- benzinga.com Tectonic Therapeutic To Make Late-breaking Oral Presentation At ESC Heart Failure 2025 Congress Highlighting Phase 1B Data For TX45 WATERTOWN, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ:TECX) ("Tectonic"), a clinical stage biotechnology company focused on the discovery and development of…
- benzinga.com Wells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $101 Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:TECX) with a Overweight and lowers the price target from $112 to $101.
- benzinga.com Tectonic Therapeutic Q4 2024 GAAP EPS $(0.84) Beats $(1.39) Estimate Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(0.84) per share which beat the analyst consensus estimate of $(1.39) by 39.57 percent.
- benzinga.com Tectonic Therapeutic Raises $185M in PIPE Deal, Issuing Shares at Up to $54.14 Each Tectonic Therapeutic, Inc. (NASDAQ:TECX) ("Tectonic"), today announced that it has entered into a securities purchase agreement for a private investment in public equity financing (the "PIPE") that…
- benzinga.com Wells Fargo Maintains Overweight on Tectonic Therapeutic, Raises Price Target to $112 Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:TECX) with a Overweight and raises the price target from $79 to $112.
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com Nasdaq Moves Lower; Meta Platforms Posts Strong Sales 
benzinga.com IBM Posts Upbeat Earnings, Joins Oshkosh, Las Vegas Sands, Nokia, Quest Diagnostics And Other Big Stocks Moving Higher On Thursday 
benzinga.com Dow Jumps Over 100 Points; Tesla Earnings Miss Views - benzinga.com Market-Moving News for January 30th IBM: 12% | IBM shares are trading higher after the company announced a collaboration agreement with Telefonica Tech Ink for quantum-safe technology. The stock may also be trading on continued…
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga.com Tectonic Therapeutic Says Interim Results Show That TX45 Achieved Improvements In Hemodynamics Which Met And Exceeded Prespecified Objectives In the overall study population, TX45 achieved a 17.9% reduction in pulmonary capillary wedge pressure ("PCWP"), an endpoint known to correlate with exercise capacity, morbidity and mortality in…
- benzinga.com Tectonic Therapeutic To Host KOL Event On The Unmet Need In Group 2 PH-HFpEF And TX45 As A Potential Treatment On Thursday, December 12, 2024 From 4:00 PM To 6:00 PM ET Tectonic Therapeutic, Inc. (NASDAQ:TECX) ("Tectonic") a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity…
- benzinga.com Raymond James Initiates Coverage On Tectonic Therapeutic with Outperform Rating, Announces Price Target of $65 Raymond James analyst Danielle Brill initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Outperform rating and announces Price Target of $65.
- benzinga.com Wells Fargo Maintains Overweight on Tectonic Therapeutic, Raises Price Target to $79 Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:TECX) with a Overweight and raises the price target from $55 to $79.
- benzinga.com Leerink Partners Maintains Outperform on Tectonic Therapeutic, Raises Price Target to $69 Leerink Partners analyst David Risinger maintains Tectonic Therapeutic (NASDAQ:TECX) with a Outperform and raises the price target from $49 to $69.